Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be at least 2 years postmenopausal~* Osteoporotic subjects without vertebral fracture who meet BMD criteria, or Osteoporotic subjects with vertebral fracture~Exclusion Criteria:~* Diseases that may affect bone metabolism~* Vasomotor symptoms requiring treatment~* Known history or suspected cancer of the breast~* Active or past history of venous thromboembolic events

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): None
- B (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).